Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-932-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- Form February 22th to March 08th, 2006
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted according to internationally accepted testing guidelines and performed in compliance with Good Laboratory Practice. Justification for read across approach is given in the endpoint summary and in the read across justification report attached to the Section 13 of this dossier.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 006
- Report date:
- 2006
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- adopted July 21, l997
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH.
- Age at study initiation: 8 - 10 weeks.
- Weight at study initiation: males mean value 34.0 g (SD ± 2.5 g); females mean value 28.7 g (SD ± 2.1 g).
- Assigned to test groups randomly: yes.
- Housing: single in cages Makrolon Type I, with wire mesh top (EHRET GmbH, D-79302 Emmendingen). Bedding was made by granulated soft wood bedding (Harlan Winkelmann GmbH, D-33178 Borchen).
- Diet: pelleted standard diet, ad Iibitum (Harlan Winkelmann GmbH, D-33178 Borchen).
- Water: tap water, ad Iibitum (Gemeindewerke, D-64380 Rossdorf).
- Acclimation period: minimum 5 dasy.
- Quarantine: according to the suppliers assurance the animals were in healthy condition. The animals were under quarantine in the animal house of the testing laboratory for a minimum of five days after their arrival. During this period the animals did not show any signs of illness or altered behaviour.
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C.
- Humidity: 26 - 70 %.
- Photoperiod: artificial light 6.00 a.m. - 6.00 p.m.
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- - Vehicle used: deionised water.
- Route of administration: oral.
- Frequency of administration: once.
- Volume administered: 10 ml/kg bw - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS
The test item was formulated in deionised water, which was also used as vehicle control. The volume administered orally was 10 ml/kg b.w.. 24 h and 48 h after a single administration of the test item the bone marrow cells were collected for micronuclei analysis.
TREATMENT
At the beginning of the treatment the animals (including the controls) were weighed and the individual volume to be administered was adjusted to the animals body weight. The animals received the test item, the vehicle or the positive control substance once. Twelve animals, six males and six females, were treated per dose group and sampling time. The animals of all dose groups were examined for acute toxic symptoms at intervals of around 1 h, 2 - 4 h, 6 h and 24 h after administration ofthe test item. - Frequency of treatment:
- Single treatment
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
500, 1000 and 2000 mg/kg bw
Basis:
nominal conc.
24 hrs preparation
- Remarks:
- Doses / Concentrations:
2000 mg/kg bw
Basis:
nominal conc.
48 hrs preparation
- No. of animals per sex per dose:
- six males and six females per group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide (CPA)
- Justification for choice of positive control: the stability of CPA at room temperature is sufficient. At 25 °C only 3.5 % of its potency is lost after 24 hours.
- Route of administration: oral.
- Frequency of administration: once.
- Volume administreted: 10 ml/kg bw
- Dissolved in: deionised water.
Examinations
- Tissues and cell types examined:
- Micronucleus in bone marrow cells
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION
It is generally recommended to use the maximum tolerated dose or the highest dose that can be formulated and administered reproducibly or 2000 mg/kg as the upper limit for non-toxic test items.
The maximum tolerated dose level is determined to be the dose that causes toxic reactions without having major effects on survival within 48 hours.
The volume to be administered should be compatible with physiological space available.
Three adequate spaced dose levels spaced by a factor of 2 were applied at the central sampling interval 24 h after treatment. For the highest dose level an additional sample was taken at 48 h after treatment.
TREATMENT AND SAMPLING TIMES
Sampling of the bone marrow was done 24 and 48 hours after treatment, respectively.
DETAILS OF SLIDE PREPARATION
The animals were sacrificed using CO2 following by bleeding. The femora were removed, the epiphyses were cutoff and the marrow was flushed out with foetal calf serum, using a syringe. The cell suspension was centrifuged at 1500 rpm (390 x g) for 10 minutes and the supernatant was discarded. A small drop of the re-suspended cell pellet was spread on a slide. The smear was air-dried and then stained with May-Grünwald /Giemsa.
Cover slips were mounted with EUKITT (KINDLER, D-79110 Freiburg). At least one slide was made from each bone marrow sample.
METHOD OF ANALYSIS
Evaluation of the slides was performed using NIKON microscopes with 100x oil immersion objectives. At least 2000 polychromatic erythrocytes (PCE) were analysed per animal for micronuclei. To describe a cytotoxic effect the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and expressed in polychromatic erythrocytes per 2000 erythrocytes. The analysis was performed with coded slides. Ten animals (5 males, 5 females) per test group were evaluated as described. The remaining G"` animal of each sex in the respective test group test group is usually evaluated in case an animal dies in its test group spontaneously. - Evaluation criteria:
- A test item is classified as mutagenic if it induces either a dose-related increase or a clear increase in the number of micronucleated polychromatic erythrocytes in a single dose group. Statistical methods (nonparametric Mann-Whitney test) will be used as an aid in evaluating the results. However, the primary point of consideration is the biological relevance of the results.
A test item that fails to produce a biological relevant increase in the number of micronucleated polychromatic erythrocytes is considered non-mutagenic in this system. - Statistics:
- Statistical significance at the five per cent level (p < 0.05) was evaluated by means of the non-parametric Mann-Whitney test.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- PRE-EXPERIMENT FOR TOXICITY
All the animals treated with 2000 mg/kg b.w. showed ruffled fur between 2 and 6 hours post-treatment. At 24 hours no signs of toxicity were observed. On the basis of the preliminary test outcomes, 2000 mg/kg b.w. were estimated to be suitable.
TOXIC SYMPTOMS IN THE MAIN EXPERIMENT
Animals treated with 2000 mg/kg bw showed ruffled fur during the first 6 hours; these effects were not more observed at 24 hours.
Ruffled fur was also recorded in animals treated with 1000 mg/kg bw, at 2 - 4 hours. At 6 hours this effect was not observed.
The animals treated with 500 mg/kg bw and the vehicle control (deionised water) animals did not show any toxic reactions.
Any other information on results incl. tables
SUMMARY OF MICRONUCLEUS TEST RESULTS
Test group | Dose mg/kg bw |
sampling time (h) | PCEs with micronuclei (%) | Range | PCE per 2000 erythocytes |
Vehicle | 0 | 24 | 0.125 | 0 - 6 | 1154 |
Test item | 500 | 24 | 0.115 | 0 - 4 | 1166 |
Test item | 1000 | 24 | 0.090 | 1 - 4 | 1157 |
Test item | 2000 | 24 | 0.095 | 0 - 5 | 1216 |
Positive control | 40 | 24 | 3.030 | 42 - 92 | 988 |
Test item | 2000 | 48 | 0.075 | 0 - 3 | 1081 |
Biometry
Vehicle control versus test group | Significance | p |
500 mg test item/kg bw; 24 h | n.t. | - |
1000 mg test item/kg bw; 24 h | n.t. | - |
2000 mg test item/kg bw; 24 h | n.t. | - |
40 mg CPA/kg bw; 24 h | + | < 0.0001 |
2000 mg test item/kg bw; 48 h | n.t. | - |
Statistical significance at the five per cent level (p < 0.05) was evaluated by means of the non-parametric Mann-Whitney test.
HISTORICAL CONTROLS - 1999 - 2004
Vehicle controls | Positive control (CPA) | |||||
Males | Females | Total | Males | Females | Total | |
Mean*± SD | 0.078± 0.04 | 0.058± 0.033 | 0.069± 0.028 | 0.078± 0.07 | 1.368± 0.497 | 1.632± 0.468 |
Range** | 0.01- 0.23 | 0.0- 0.19 | 0.01- 0.15 | 0.70- 3.46 | 0.49- 3.55 | 0.77- 3.48 |
N. of experiments | 229 | 217 | 230 | 228 | 217 | 229 |
*: mean value (percent micrcnucleated cells)
**: range of the mean group values (percent micronucleated cells)
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Under the experimental conditions reported, the test item did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse. - Executive summary:
This study was performed to investigate the potential of the test item to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the mouse. The test item was formulated in deionised water, which was also used as vehicle control. The volume administered orally was 10 ml/kg b.w.. 24 h and 48 h after a single administration of the test item the bone marrow cells were collected for micronuclei analysis.
Ten animals (5 males, 5 females) per test group were evaluated for the occurrence of micronuclei. At least 2000 polychromatic erythrocytes (PCEs) per animal were scored for micronuclei.
To describe a cytotoxic effect due to the treatment with the test item the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and reported as the number of PCEs per 2000 erythrocytes.
The following dose levels of the test item were investigated: 24 h preparation interval 500, 1000, and 2000 mg/kg b.w.; 48 h preparation interval 2000 mg/kg b.w.. The highest dose (2000 mg/kg; maximum guideline-recommended dose) was estimated by a pre-experiment to be suitable.
After treatment with the test item the number of PCEs was not substantially decreased as compared to the mean value of PCEs of the vehicle control thus indicating that the substance did not exert any cytotoxic effects in the bone marrow.
In comparison to the corresponding vehicle controls there was no biologically relevant or statistically significant enhancement in the frequency of the detected micronuclei at any preparation interval after administration of the test item and with any dose level used.
40 mg/kg b.w. cyclophosphamide administered orally was used as positive control which showed a substantial increase of induced micronucleus frequency.
Conclusion
Under the experimental conditions reported, the test item did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse.
Therefore, the substance is considered to be non-mutagenic in this micronucleus assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.